RemAb Therapeutics attended The challenge of MDR and XDR infections Workshop.

Dr. Mañez, president and CMO of RemAb Therapeutics talked on September the 14th about the important role of Anti-αGal antibodies in infectious disease at “The challenge of MDR and XDR infections” and presenting our company to the scientific community.


More infomation